Kavita Singh

ORCID: 0000-0003-4330-666X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes Management and Education
  • Global Public Health Policies and Epidemiology
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Chronic Disease Management Strategies
  • COVID-19 Clinical Research Studies
  • Cardiac Health and Mental Health
  • COVID-19 and healthcare impacts
  • Healthcare Systems and Reforms
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Health and Risk Factors
  • Pharmaceutical Economics and Policy
  • Long-Term Effects of COVID-19
  • Diabetes Management and Research
  • Medication Adherence and Compliance
  • Lipoproteins and Cardiovascular Health
  • Health Policy Implementation Science
  • Mobile Health and mHealth Applications
  • Health disparities and outcomes
  • Health and Lifestyle Studies
  • Mindfulness and Compassion Interventions
  • Global Health Care Issues
  • Artificial Intelligence in Healthcare
  • Telemedicine and Telehealth Implementation
  • Pharmaceutical Practices and Patient Outcomes

Public Health Foundation of India
2016-2025

Centre for Chronic Disease Control
2015-2025

Heidelberg University
2022-2025

University Hospital Heidelberg
2022-2025

Arizona State University
2024

Washington University in St. Louis
2024

Jawaharlal Nehru University
2023

Global Policy Institute
2023

Emory University
2016-2021

Stanford University
2020

Abstract Background People with chronic conditions are disproportionately prone to be affected by the COVID-19 pandemic but there limited data documenting this. We aimed assess health, psychosocial and economic impacts of on people in India. Methods Between July 29, September 12, 2020, we telephonically surveyed adults ( n = 2335) across four sites Data participants’ demographic, socio-economic status, comorbidities, access health care, treatment satisfaction, self-care behaviors,...

10.1186/s12889-021-10708-w article EN cc-by BMC Public Health 2021-04-08

The burden of noncommunicable diseases and their risk factors has rapidly increased worldwide, including in India. Innovative management strategies with electronic decision support task sharing have been assessed for hypertension, diabetes mellitus, depression individually, but an integrated package multiple chronic condition primary care not evaluated.In a prospective, multicenter, open-label, cluster-randomized controlled trial involving 40 community health centers, using hypertension...

10.1161/circulationaha.118.038192 article EN cc-by Circulation 2019-01-14

This review article describes the pathophysiological mechanisms linking Apolipoprotein B (Apo-B) and atherosclerosis, summarizes existing evidence on Apo as a predictor of atherosclerotic cardiovascular disease recommendations (inter)national treatment guidelines regarding in dyslipidemia management. A single molecule is present every particle very low-density lipoprotein, intermediate density low lipoprotein(a). unique per ratio makes plasma concentration direct measure number circulating...

10.1016/j.ihj.2023.12.001 article EN cc-by-nc-nd Indian Heart Journal 2024-03-01

People with chronic conditions are known to be vulnerable the COVID-19 pandemic. This study aims describe patients' lived experiences, challenges faced by people conditions, their coping strategies, and social economic impacts of pandemic.We conducted a qualitative using syndemic framework understand experiences disease care, during lockdown, strategies mitigators pandemic in context socioecological biological factors. A diverse sample 41 participants (hypertension, diabetes, stroke...

10.1136/bmjopen-2021-048926 article EN cc-by-nc BMJ Open 2021-06-01

This study aims to provide evidence on how the COVID-19 pandemic has impacted chronic disease care in diverse settings across Asia. Cross-sectional surveys were conducted assess health, social, and economic consequences of India, China, Hong Kong, Korea, Vietnam using standardized questionnaires. Overall, 5672 participants with conditions recruited from five countries. The mean age ranged 55.9 69.3 years. A worsened status during was reported by 19% 59% participants. Increased difficulty...

10.1177/10105395211073052 article EN Asia Pacific Journal of Public Health 2022-01-22

<strong>Background and aims:</strong> Limited data exist on the cardiovascular manifestations risk factors in people hospitalized with COVID-19 from low- middle-income countries. This study aims to describe factors, clinical manifestations, outcomes among patients low, lower-middle, upper-middle- high-income countries (LIC, LMIC, UMIC, HIC). <strong>Methods:</strong> Through a prospective cohort study, demographics pre-existing conditions at hospital admission, discharge (death, major...

10.5334/gh.1128 article EN cc-by Global Heart 2022-01-01

Importance Aspirin is an effective and low-cost option for reducing atherosclerotic cardiovascular disease (CVD) events improving mortality rates among individuals with established CVD. To guide efforts to mitigate the global CVD burden, there a need understand current levels of aspirin use secondary prevention Objective report evaluate across low-, middle-, high-income countries. Design, Setting, Participants Cross-sectional analysis using pooled, individual participant data from nationally...

10.1001/jama.2023.12905 article EN JAMA 2023-08-22

Health-related quality of life (HRQOL) is a key indicator health. However, HRQOL data from representative populations in South Asia are lacking. This study aims to describe overall, by age, gender and socioeconomic status, examine the associations between selected chronic conditions adults three urban cities Asia.We used 16 287 aged ≥20 years baseline survey Centre for Cardiometabolic Risk Reduction cohort (2010-2011). was measured using European Quality Life Five Dimension-Visual Analogue...

10.1136/bmjopen-2017-018424 article EN cc-by BMJ Open 2017-10-01

Recent data on sustained hypertension and obesity among school-going children adolescents in India are limited. This study evaluates the prevalence of their risk factors urban rural northern India.A school-based, cross-sectional survey was conducted areas Ludhiana, Punjab, using standardised measurement tools.A total 1959 participants aged 11-17 years (urban: 849; rural: 1110) were included this school-based survey.To measure school children, two distinct blood pressure (BP) measurements...

10.1136/bmjopen-2018-027134 article EN cc-by-nc BMJ Open 2019-09-01

Cardiovascular diseases (CVDs) are the leading cause of death in most low- and middle-income countries (LMICs). CVDs their metabolic risk factors have historically been concentrated among urban residents with higher socioeconomic status (SES) LMICs such as India. However, India develops, it is unclear whether these geographic gradients will persist or change. Understanding social dynamics CVD essential for mitigating rising burden to reach those greatest needs.Using nationally representative...

10.1016/j.lansea.2023.100188 article EN cc-by The Lancet Regional Health - Southeast Asia 2023-04-14

In India, for most patients, primary healthcare remains the intended entry point management of non-communicable disease risk factors. The extent and determinants non-utilisation public care among households with hypertension are not well examined. We explored health facility utilisation patterns reasons facilities in 21 states union territories a focus on hypertension.We used data from 2012-2013 District Level Household Facility Survey. examined self-reported usual source all households,...

10.1136/bmjgh-2018-001002 article EN cc-by BMJ Global Health 2018-12-01

A rising burden of chronic non-communicable diseases (CNCDs) increases demand for outpatient healthcare. Yet, evidence on preferences and barriers to healthcare services India's most disadvantaged population, the target largest public health insurance scheme (PM-JAY), is lacking. We explore determinants healthcare-seeking behavior among PM-JAY eligible individuals with CNCDs in rural areas seven states. Using cross-sectional data from a household survey (conducted between November 2019 March...

10.1080/16549716.2025.2480413 article EN cc-by Global Health Action 2025-04-14

Importance The Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE) trial has shown improved adherence with the use polypill strategy when compared usual medications for disease (CVD) prevention. To advance from efficacy to impact, we need better understanding why and how such might be deployed in complex health systems. Objective understand, perspective UMPIRE participants professionals, improves care, improvement is greater some subgroups, explore acceptability among...

10.1136/bmjopen-2015-008018 article EN cc-by BMJ Open 2015-09-01
Coming Soon ...